logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Atherosclerosis

    FiltersReset Filters
    16 results

    • crestor

      (Rosuvastatin)
      AstraZeneca Pharmaceuticals LP
      Usage: CRESTOR is indicated for reducing the risk of major cardiovascular events in adults at increased risk, as an adjunct to diet for lowering LDL cholesterol in various hyperlipidemias, and for treating primary dysbetalipoproteinemia and hypertriglyceridemia in adults. It is also used in pediatric patients with familial hypercholesterolemia.

    • ezallor sprinkle

      (ROSUVASTATIN)
      Sun Pharmaceutical Industries, Inc.
      Usage: EZALLOR SPRINKLE is indicated to reduce the risk of major adverse cardiovascular events in at-risk adults, lower LDL cholesterol in various hyperlipidemia types, and treat primary dysbetalipoproteinemia and hypertriglyceridemia in adults. It can be used alone or with other LDL-lowering therapies for patients with familial hypercholesterolemia.

    • lodoco

      (Colchicine Tablets 0.5 mg)
      AGEPHA Pharma USA, LLC
      Usage: LODOCO is indicated for reducing the risk of myocardial infarction, stroke, coronary revascularization, and cardiovascular death in adults with established atherosclerotic disease or multiple cardiovascular disease risk factors.

    • niacin

      (Niacin)
      Chartwell RX, LLC
      Usage: Niacin extended-release tablets are indicated as an adjunct to diet for reducing elevated cholesterol and triglycerides, increasing HDL, and decreasing the risk of recurrent myocardial infarction in hyperlipidemic patients. It also helps slow atherosclerotic disease progression in those with a history of coronary artery disease.

    • rosuvastain calcium

      (Rosuvastain Calcium)
      Chartwell RX, LLC
      Usage: Rosuvastatin tablets are indicated to reduce cardiovascular risks in adults without coronary heart disease, lower LDL cholesterol in hyperlipidemia, slow atherosclerosis progression, and treat familial hypercholesterolemia in patients aged 7 years and older, alongside dietary management and adjunct therapies.

    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      Shandong New Time Pharmaceutical Co., Ltd.
      Usage: Rosuvastatin is indicated for reducing cardiovascular risk in adults without coronary heart disease, lowering LDL-C in various hyperlipidemia types, treating familial hypercholesterolemia in children and adults, and addressing primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet and other therapies.

    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      UMEDICA LABORATORIES PRIVATE LIMITED
      Usage: Rosuvastatin is indicated to reduce cardiovascular event risk in adults without coronary heart disease, lower LDL cholesterol in various forms of hyperlipidemia (primary, familial), and treat dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet in both adults and pediatric patients aged 7 years and older.

    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      TORRENT PHARMACEUTICALS LIMITED
      Usage: Rosuvastatin is indicated to reduce the risk of major cardiovascular events in adults at increased risk, and as an adjunct to diet for lowering LDL cholesterol in various conditions, including primary hyperlipidemia, heterozygous familial hypercholesterolemia, and homozygous familial hypercholesterolemia in both adults and children.

    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      Cadila Pharmaceuticals Limited
      Usage: Rosuvastatin tablets are indicated for reducing cardiovascular disease risk in adults, managing hyperlipidemia, and treating familial hypercholesterolemia in patients aged 7 and older. They also help reduce LDL-C and slow atherosclerosis progression, and are used alongside diet and other therapies for cholesterol control.

    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      Ascend Laboratories, LLC
      Usage: Rosuvastatin tablets are indicated to reduce cardiovascular risks in adults at increased risk, lower LDL-C in those with primary hyperlipidemia, and treat heterozygous or homozygous familial hypercholesterolemia in pediatric and adult patients. It also aids in managing primary dysbetalipoproteinemia and hypertriglyceridemia.